1 |
Skov R, Christiansen K, Dancer SJ, et al. Update on the prevention and control of community-acquired meticillin-resistant Staphylococcus aureus (CA-MRSA)[J]. Int J Antimicrob Agents, 2012, 39(3): 193-200.
|
2 |
Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults[J]. Clin Infect Dis, 2007, 44 Suppl 2: S27-S72.
|
3 |
Wu D, Wang Q, Yang Y, et al. Epidemiology and molecular characteristics of community-associated methicillin-resistant and methicillin-susceptible Staphylococcus aureus from skin/soft tissue infections in a children′s hospital in Beijing[J]. Diagn Microbiol Infect Dis, 2010, 67(1): 1-8.
|
4 |
Song JH, Hsueh PR, Chung DR, et al. Spread of methicillin-resistant Staphylococcus aureus between the community and the hospitals in Asian countries: an ANSORP study[J]. J Antimicrob Chemother, 2011, 66(5): 1061-1069.
|
5 |
Otter JA, French GL. Community-associated meticillin-resistant Staphylococcus aureus: the case for a genotypic definition [J]. J Hosp Infect, 2012, 81(3): 143-148.
|
6 |
Mediavilla JR, Chen L, Mathema B, et al. Global epidemiology of community-associated methicillin resistant Staphylococcus aureus (CA-MRSA)[J]. Curr Opin Microbiol, 2012, 15(5): 588-595.
|
7 |
Obed M, García-Vidal C, Pessacq P, et al. Clinical features and outcome of community-acquired methicillin-resistant Staphylococcus aureus pneumonia[J]. Enferm Infecc Microbiol Clin, 2014, 32(1): 23-27.
|
8 |
Leonard SN, Cheung CM, Rybak MJ. Activities of ceftobiprole, linezolid, vancomycin, and daptomycin against community-associated and hospital-associated methicillin-resistant Staphylococcus aureus[J]. Antimicrob Agents Chemother, 2008, 52(8): 2974-2976.
|
9 |
Karampela I, Poulakou G, Dimopoulos G. Community acquired methicillin resistant Staphylococcus aureus pneumonia: an update for the emergency and intensive care physician [J]. Minerva Anestesiol, 2012, 78(8): 930-940.
|
10 |
Huson MA, Kalkman R, Remppis J, et al. Methicillin-resistant Staphylococcus aureus as a cause of invasive infections in Central Africa: a case report and review of the literature[J]. Infection, 2014, 42(3): 451-457.
|
11 |
Bassetti M, Baguneid M, Bouza E, et al. European perspective and update on the management of complicated skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus after more than 10 years of experience with linezolid[J]. Clin Microbiol Infect, 2014, 20 Suppl 4: 3-18.
|
12 |
Gudiol F, Aguado JM, Almirante B, et al. Diagnosis and treatment of bacteremia and endocarditis due to Staphylococcus aureus. A clinical guideline from the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC)[J]. Enferm Infecc Microbiol Clin, 2015, 33(9): 625. e1-23.
|